Risk factors for raltegravir resistance development in clinical practice.
Malet I, Fourati S, Morand-Joubert L, Flandre P, Wirden M, Haim-Boukobza S, Sayon S, Pattery T, Simon A, Katlama C, Girard PM, Calvez V, Marcelin AG.
Malet I, et al. Among authors: pattery t.
J Antimicrob Chemother. 2012 Oct;67(10):2494-500. doi: 10.1093/jac/dks254. Epub 2012 Jul 4.
J Antimicrob Chemother. 2012.
PMID: 22763565